A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma
Open Access
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 11 (6) , 838-849
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health/National Cancer Institute (CA90489)
- Specialized Programs of Research Excellence (CA119997)
This publication has 44 references indexed in Scilit:
- Different prognostic impact ofSTK11mutations in non-squamous non-small-cell lung cancerOncotarget, 2015
- Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinomaOncogene, 2015
- Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung CancerJNCI: Journal of the National Cancer Institute, 2014
- Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung CancersScience Translational Medicine, 2013
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseNature, 2012
- mTOR Inhibitor Treatment of Pancreatic Cancer in a Patient With Peutz-Jeghers SyndromeJournal of Clinical Oncology, 2011
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucoseThe Journal of Thoracic and Cardiovascular Surgery, 2009
- A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesisBiochemical Journal, 2008
- Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancerOncogene, 2006